Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
about
Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumorsCorrelation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinomaGemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes.Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.New findings on thymic epithelial tumors: Something is changing.Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic TargetsPretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.Novel Agents in the Treatment of Thymic Malignancies.Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma.Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma.Thymic tumors and immune checkpoint inhibitors.Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors.Combining immunotherapy with radiation therapy in thoracic oncology
P2860
Q33644049-142047F3-0A4D-44D2-8B57-71A4095444F0Q33645601-84697980-03AB-473B-AFB4-26B178D03E1BQ35936010-76ED9E67-3A08-4657-AB2C-1FD777A9F1D2Q38662451-E6B4A7C9-E560-4BBA-954C-8845328D1BCDQ38856818-04F1F866-C1D4-4046-8F42-09E4A4C7B04CQ39783701-A33EFA4A-84AA-430A-BD29-CD676524FD6CQ40096396-270C4ABE-8315-4CE8-B1AC-9CE69E7D6674Q40430354-935F24D1-275A-4988-934C-F3933D041E87Q41021890-C34B54EB-574F-474C-9E04-851E71C698F0Q42331961-86723418-089B-460C-93F1-4F0115FB3141Q45491251-909DFF49-6EEF-4B9F-9C6C-A7852F644955Q48696917-261E3548-9DBD-49F8-B920-2F79953E3A2CQ49643762-7411FB39-B808-4DD3-8ADD-E53D966783CBQ50636979-32717262-DE63-4962-BFA6-962CA0CC103BQ52893153-E83274B6-D221-4799-8694-C52B5254CCE7Q55229901-738FC3ED-2F96-4053-A848-64651A635F94Q55339393-2E6375BA-0D20-4F54-91D0-E96FA0E51C7FQ55371736-0C51B3CB-D4CC-4EC5-8D0D-CCD3963FF650Q58804834-10D38F5C-58CF-47C9-94BF-7A0D27C12DAF
P2860
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@ast
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@en
type
label
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@ast
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@en
prefLabel
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@ast
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@en
P2093
P2860
P1476
Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
@en
P2093
Erich J Schwartz
Heather A Wakelee
Holbrook E Kohrt
Joel W Neal
Jonathan W Riess
Robert B West
Sukhmani K Padda
P2860
P304
P356
10.1097/JTO.0000000000000429
P577
2015-03-01T00:00:00Z